P., S., C., C., & M., M. (2014). Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.
Chicago Style CitationP., Suprasert, Cheewakriangkrai C., and Manopunya M. Outcome of Single Agent Generic Gemcitabine in Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer and Primary Peritoneal Adenocarcinoma. 2014.
MLA CitationP., Suprasert, Cheewakriangkrai C., and Manopunya M. Outcome of Single Agent Generic Gemcitabine in Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer and Primary Peritoneal Adenocarcinoma. 2014.
Warning: These citations may not always be 100% accurate.